| Pharmacogenetic clinical randomised Phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer … D Páez, M Tobeña, J Fernández-Plana, A Sebio, AC Virgili, L Cirera, ... British journal of cancer 120 (2), 190-195, 2019 | 39 | 2019 |
| Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain L Gonzalez-Quereda, MJ Rodriguez, J Diaz-Manera, J Alonso-Perez, ... Genes 11 (5), 539, 2020 | 36 | 2020 |
| Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients I Sullivan, P Riera, M Andrés, A Altés, M Majem, R Blanco, L Capdevila, ... Angiogenesis 22, 433-440, 2019 | 31 | 2019 |
| Gefitinib and afatinib show potential efficacy for Fanconi anemia–related head and neck cancer H Montanuy, Á Martínez-Barriocanal, J Antonio Casado, L Rovirosa, ... Clinical Cancer Research 26 (12), 3044-3057, 2020 | 25 | 2020 |
| ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients P Riera, A Artigas-Baleri, J Salazar, A Sebio, AC Virgili, MJ Arranz, ... Frontiers in Pharmacology 11, 973, 2020 | 20 | 2020 |
| Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan‐induced severe toxicity P Riera, J Salazar, AC Virgili, M Tobeña, A Sebio, P Gallano, A Barnadas, ... British journal of clinical pharmacology 84 (6), 1389-1392, 2018 | 19 | 2018 |
| Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer P Riera, AC Virgili, J Salazar, A Sebio, M Tobeña, I Sullivan, D Páez The pharmacogenomics journal 18 (4), 556-564, 2018 | 13 | 2018 |
| Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y‐Site Admixtures for Neonates P Riera, G Garrido‐Alejos, J Cardenete, E Moliner, E Zapico‐Muñiz, ... Nutrition in Clinical Practice 33 (5), 694-700, 2018 | 12 | 2018 |
| Physicochemical compatibility of amiodarone with parenteral nutrition MM Mediavilla, A Molina, L Navarro, L Grau, MD Pujol, J Cardenete, ... Journal of Parenteral and Enteral Nutrition 43 (2), 298-304, 2019 | 11 | 2019 |
| CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative J Luque, I Mendes, B Gómez, B Morte, M López de Heredia, E Herreras, ... Clinical Genetics 101 (5-6), 481-493, 2022 | 9 | 2022 |
| Physicochemical compatibility of dexmedetomidine with parenteral nutrition Y Campos‐Baeta, M Saavedra‐Mitjans, N Garin, J Cardenete, D Cardona, ... Nutrition in Clinical Practice 35 (5), 967-972, 2020 | 8 | 2020 |
| Elucidating the role of pharmacogenetics in irinotecan efficacy and adverse events in metastatic colorectal cancer patients P Riera, D Páez Expert Opinion on Drug Metabolism & Toxicology 17 (10), 1157-1163, 2021 | 7 | 2021 |
| A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence D Medina-Catalán, P Riera, N Pagès-Puigdemont, M Masip, ... International Journal of Clinical Pharmacy 44 (3), 725-730, 2022 | 6 | 2022 |
| An integrated multidisciplinary circuit led by hospital and community pharmacists to implement clopidogrel pharmacogenetics in clinical practice JF Mir, C Rodríguez-Caba, M Estrada-Campmany, ... Pharmacy 11 (2), 76, 2023 | 3 | 2023 |
| Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis L Sainz, P Riera, P Moya, S Bernal, J Casademont, C Díaz-Torné, ... Pharmaceutics 14 (9), 1942, 2022 | 3 | 2022 |
| AB0402 THERAPEUTIC ADHERENCE AND PERSISTENCE OF TOFACITINIB AND BARICITINIB IN RHEUMATOID ARTHRITIS PATIENTS IN DAILY CLINICAL PRACTICE. H Codes-Mendez, C Martinez-Molina, M Masip, P Riera, NP Puigdemont, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1330-1330, 2022 | 3 | 2022 |
| Dosificació de fàrmacs en pacients obesos EF de Gamarra Martínez, PR Armengol, NS Fabre Generalitat de Catalunya 24 (4), 2013 | 3 | 2013 |
| Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide I Conejo, N Mas-Malagarriga, P Riera, J Cardenete, R Puig-Piña Nutr Hosp 39 (1), 230-232, 2022 | 2 | 2022 |
| Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients P Riera, B Rodríguez-Santiago, A Lasa, L Gonzalez-Quereda, B Martín, ... Cancers 12 (8), 2245, 2020 | 2 | 2020 |
| Assessment of gentamicin dosing regimens in newborns treated with hypothermia P Riera, N Solé, E Fernández de Gamarra, E Moliner, MJ Garcia, ... INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 35 (6), 1271-1271, 2013 | 2 | 2013 |
Noé Garin EscrivaHospital de la Santa Creu i Sant Pau, Barcelona, SpainVerified email at santpau.cat
